Homo sapiens Protein: KCNMA1 | |||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||||||||||
InnateDB Protein | IDBP-295416.6 | ||||||||||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||||||||||
Gene Symbol | KCNMA1 | ||||||||||||||||||||||||||||||||||
Protein Name | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 | ||||||||||||||||||||||||||||||||||
Synonyms | bA205K10.1; BKTM; KCa1.1; MaxiK; mSLO1; SAKCA; SLO; SLO-ALPHA; SLO1; | ||||||||||||||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||||||||||||||
Ensembl Protein | ENSP00000385806 | ||||||||||||||||||||||||||||||||||
InnateDB Gene | IDBG-79612 (KCNMA1) | ||||||||||||||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||||||||||||||
Function | Potassium channel activated by both membrane depolarization or increase in cytosolic Ca(2+) that mediates export of K(+). It is also activated by the concentration of cytosolic Mg(2+). Its activation dampens the excitatory events that elevate the cytosolic Ca(2+) concentration and/or depolarize the cell membrane. It therefore contributes to repolarization of the membrane potential. Plays a key role in controlling excitability in a number of systems, such as regulation of the contraction of smooth muscle, the tuning of hair cells in the cochlea, regulation of transmitter release, and innate immunity. In smooth muscles, its activation by high level of Ca(2+), caused by ryanodine receptors in the sarcoplasmic reticulum, regulates the membrane potential. In cochlea cells, its number and kinetic properties partly determine the characteristic frequency of each hair cell and thereby helps to establish a tonotopic map. Kinetics of KCNMA1 channels are determined by alternative splicing, phosphorylation status and its combination with modulating beta subunits. Highly sensitive to both iberiotoxin (IbTx) and charybdotoxin (CTX). | ||||||||||||||||||||||||||||||||||
Subcellular Localization | Cell membrane {ECO:0000269PubMed:20693285, ECO:0000269PubMed:22399288}; Multi-pass membrane protein {ECO:0000269PubMed:20693285, ECO:0000269PubMed:22399288}. | ||||||||||||||||||||||||||||||||||
Disease Associations | Generalized epilepsy and paroxysmal dyskinesia (GEPD) [MIM:609446]: Epilepsy is one of the most common and debilitating neurological disorders. Paroxysmal dyskinesias are neurological disorders characterized by sudden, unpredictable, disabling attacks of involuntary movement often requiring life-long treatment. The coexistence of epilepsy and paroxysmal dyskinesia in the same individual or family is an increasingly recognized phenomenon. Patients manifest absence seizures, generalized tonic- clonic seizures, paroxysmal nonkinesigenic dyskinesia, involuntary dystonic or choreiform movements. Onset is usually in childhood and patients may have seizures only, dyskinesia only, or both. {ECO:0000269PubMed:15937479}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||||||||||||||||||
Tissue Specificity | Widely expressed. Except in myocytes, it is almost ubiquitously expressed. {ECO:0000269PubMed:11880513}. | ||||||||||||||||||||||||||||||||||
Comments | |||||||||||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 16 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||||||||||||||
InterPro |
IPR003091
Potassium channel IPR003148 Regulator of K+ conductance, N-terminal IPR003929 Potassium channel, calcium-activated, BK, alpha subunit IPR005821 Ion transport domain IPR013099 Two pore domain potassium channel domain |
||||||||||||||||||||||||||||||||||
PFAM |
PF02254
PF03493 PF00520 PF07885 |
||||||||||||||||||||||||||||||||||
PRINTS |
PR00169
PR01449 |
||||||||||||||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||||||||||||||
SMART | |||||||||||||||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||||||||||||||
Modification | |||||||||||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||||||||||
SwissProt | Q12791 | ||||||||||||||||||||||||||||||||||
PhosphoSite | PhosphoSite-Q12791 | ||||||||||||||||||||||||||||||||||
TrEMBL | |||||||||||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||||||||||
Entrez Gene | 3778 | ||||||||||||||||||||||||||||||||||
UniGene | Hs.144795 | ||||||||||||||||||||||||||||||||||
RefSeq | NP_001258447 | ||||||||||||||||||||||||||||||||||
HUGO | HGNC:6284 | ||||||||||||||||||||||||||||||||||
OMIM | 600150 | ||||||||||||||||||||||||||||||||||
CCDS | |||||||||||||||||||||||||||||||||||
HPRD | 15967 | ||||||||||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||||||||||
EMBL | AB113382 AB113575 AC011439 AC021032 AC067745 AF025999 AF118141 AL157833 AL607069 AL627447 AL731556 AL731560 AL731575 AY040849 BC062659 BC137115 BC137137 CH471083 U02632 U09384 U11058 U11717 U13913 U23767 | ||||||||||||||||||||||||||||||||||
GenPept | AAA50173 AAA50216 AAA85104 AAA92290 AAB65837 AAB88802 AAC50353 AAD31173 AAH62659 AAI37116 AAI37138 AAK91504 BAD06365 BAD06397 CAI14074 CAI14082 CAI16162 CAI16171 CAI39730 CAI39736 CAI40870 CAI40877 EAW54599 | ||||||||||||||||||||||||||||||||||